We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Healthpeak (DOC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
Wall Street analysts expect Healthpeak (DOC - Free Report) to post quarterly earnings of $0.46 per share in its upcoming report, which indicates a year-over-year increase of 2.2%. Revenues are expected to be $697.54 million, up 0.3% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Healthpeak metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts' assessment points toward 'Revenues- Interest income and other' reaching $15.84 million. The estimate indicates a year-over-year change of +102.3%.
The consensus estimate for 'Revenues- Rental and related revenues' stands at $539.47 million. The estimate points to a change of -1.3% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Revenues- Resident fees and services' of $150.98 million. The estimate suggests a change of +7.2% year over year.
It is projected by analysts that the 'Depreciation and amortization' will reach $265.84 million.
Shares of Healthpeak have experienced a change of +7.1% in the past month compared to the +5.4% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), DOC is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Healthpeak (DOC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Wall Street analysts expect Healthpeak (DOC - Free Report) to post quarterly earnings of $0.46 per share in its upcoming report, which indicates a year-over-year increase of 2.2%. Revenues are expected to be $697.54 million, up 0.3% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Healthpeak metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts' assessment points toward 'Revenues- Interest income and other' reaching $15.84 million. The estimate indicates a year-over-year change of +102.3%.
The consensus estimate for 'Revenues- Rental and related revenues' stands at $539.47 million. The estimate points to a change of -1.3% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Revenues- Resident fees and services' of $150.98 million. The estimate suggests a change of +7.2% year over year.
It is projected by analysts that the 'Depreciation and amortization' will reach $265.84 million.
View all Key Company Metrics for Healthpeak here>>>Shares of Healthpeak have experienced a change of +7.1% in the past month compared to the +5.4% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), DOC is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .